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Abstract
Background: Primary natural killer (NK)/T cell lymphoma of adrenal glands is an extremely rare tumor with
aggressive clinical behavior. There have only been a few cases reported worldwide and the highest reported
survival was 90 days. We report the first case of primary unilateral adrenal NK/T cell lymphoma in China with good
outcome.
Case presentation: This is a 28-year-old man who presented with abdominal pain and was found to have a large
mass on the left adrenal and the top of the renal region. The patient underwent surgical resection and the
pathology revealed primary adrenal NK/T cell lymphoma. He received adjuvant sandwich therapy encompassing
sequential chemotherapy, radiotherapy and chemotherapy. The patient remains clinically and symptomatically
disease-free with over two years follow up.
Conclusion: Given the rarity of this disease, there is limited experience with regard to its diagnosis and treatment.
This case report will add to the scant literature on this tumor and will be useful for the differential diagnosis and
treatment of adrenal disease.
Keywords: Primary natural killer/T cell lymphoma, Adrenal glands, Trimodality treatment
Background
There have been seven reported cases of NK/T cell
lymphoma involving adrenal masses worldwide [1–7].
Among them, only one was primary adrenal NK/T
cell lymphoma [2]. There have been no reported cases
of the primary adrenal NK/T-cell lymphoma in China.
Anatomically, it usually originates in the nasal cavity/
nasopharynx and invades the surrounding tissues.
Sometimes, it can arise in other organs including the
skin, spleen/liver, or the gastrointestinal tract [8].
Here, we report a primary unilateral adrenal NK/T
cell lymphoma with subsequent management. Al-
though the longest survival was reported to be 90 days
for adrenal NK/T cell lymphoma, our patient has
been disease-free for 26 months.
Case presentation
Case report
A 28-year-old male experienced abdominal pain and a
mass on the left side of the abdomen. Color duplex
ultrasonogram and subsequent computed tomography
(CT) scan revealed a 10 × 9 cm adrenal mass invading
the top of left renal and partial of retroperitoneal region
(Fig. 1. a and b). He underwent surgical removal of the
mass in an outside hospital. The pathology specimens
were evaluated in our hospital which showed neoplastic
infiltration of pleomorphic lymphoid cells with scanty
cytoplasm, irregular nuclear contour, and prominent nu-
cleoli. Immunohistochemistry analysis showed that the
tumor cells were positive for CD2, Bcl-2, CD43, CD56,
negative for CD20, CD4, CD5, CD7, CD8, CD138, PCK,
HMB45, Des, Pax-5, Bcl-6, Vim, CD34, TdT, MPO and
equivocal for CD3. Ki67 labelling index was 40% (Fig. 2).
Chromogenic in situ hybridization (CISH) was positive
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for the EBER gene (Fig. 3). These are consistent with
NK/T-cell lymphoma.
After the surgery, the patient was without any systemic
symptoms. He did have a 10 kg weight loss secondary to
the removal of the majority of the large mass and the
poor postoperative nutrition support. The postoperative
physical examination was unremarkable. A postopera-
tive CT scan of the abdomen showed a residual
tumor, measuring 2.7 × 5.3 cm at the left side of ret-
roperitoneum with the absence of left adrenal gland
and kidney (Fig. 1. c). The bone marrow biopsy was
negative. Nasal magnetic resonance imaging (MRI)
showed normal findings. The contrast CT scans of
the neck, chest and pelvis had been done and showed
normal tissue structure. Primary unilateral adrenal
NK/T cell lymphoma was diagnosed. He received four
cycles of chemotherapy with cyclophophamide, doxorubi-
cin, vincristine and prednisolone (CHOP). A post-
chemotherapy CT scan revealed no residual disease
(Fig. 1. d). He then underwent a course of consolidated
intensity-modulated radiotherapy to the surgical bed to a
dose of 50Gy in 25 fractions. Post-radiotherapy, the pa-
tient received two more cycles of CHOP. The patient tol-
erated treatment well without significant side effects. At
the 26 months follow up point, the patient remains clinic-
ally and symptomatically disease-free.
Fig. 1 Abdominal CT scans. An abdominal axial CT scan indicates a large left adrenal mass that had invaded retroperitoneal cavity before surgery
(a). A reconstructed coronal CT image shows that the top of left kidney was invaded by the tumor (b). An abdominal axial CT scan shows a
residual mass after the surgery (c). An abdominal axial CT scan shows a complete response after the postoperative chemotherapy with four cycles
of CHOP (d)
Fig. 2 Histological and immunohistochemical analysis. Neoplastic infiltrate of relatively pleomorphic lymphoid cells with scanty cytoplasm,
irregular nuclear contour, and prominent nucleoli (hematoxylin and eosin, magnification × 400). Immunohistochemical staining demonstrates
positive (magnification × 400) for CD43, CD2, CD56, but negative (magnification × 200) for CD20, CD5, CD7, Pax-5
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Discussion
Primary adrenal lymphoma or lymphoma involving
mainly the adrenal gland without the regional lymph
node involvement is a very rare extra-nodal lymph-
oma. Patients with adrenal lymphoma may present
with systemic symptoms including fever, fatigueand
weight loss [9–11]. Primary adrenal lymphoma can be
discovered incidentally on abdominal imaging. Differ-
ential diagnoses include cortical adenoma, pheochro-
mocytoma, metastatic-disease, and adrenocorticotropic
hormone (ACTH) dependent Cushing’s syndrome [12, 13].
The definitive diagnosis of primary adrenal lymphoma is
made by an image-guided percutaneous biopsy, surgical
exploration, or a postmortem examination [1, 2, 14].
Histopathologically, the most common type of primary ad-
renal lymphoma is B-cell type, mainly diffuse large B-cell
lymphoma. Although involvement of the adrenal glands
can be seen in disseminated disease, primary NK/T cell
lymphoma in the adrenal gland as an initial presentation is
extremely rare. The NK/T cell lymphomas are aggressive
lymphoproliferative disorders derived from either activated
NK cells or cytotoxic T cells. The 2008 World
Organization classification system categorized NK–cell
malignancies into three types: extra-nodal NK/T-cell
lymphoma (nasal and non-nasal), aggressive NK-cell
leukemia and chronic lymphoproliferative disorder of NK
cells [15]. NK/T-cell lymphomas demonstrate vascular de-
struction with prominent necrosis. Immunophenotypically,
they express CD2 and CD56. NK/T-cell lymphomas are
strongly associated with Epstein-Barr virus (EBV), suggest-
ing a pathogenic role of this virus [16, 17]. In this case, the
patient’s tumor was positive for CD2, CD56 and EBER.
NK/T cell lymphoma is an extra-nodal lymphoma with
predilection for the nasal cavity, nasopharynx, skin, and
the other extra-nodal sites. The primary adrenal NK/
Tcell lymphoma is exceedingly uncommon. In the review
of the literature, we found only seven reported cases of
NK/T cell lymphoma presenting as adrenal masses.
Among these cases, the adrenal mass was the only in-
volved site in one case [9]. The rest involved multiple or-
gans, including central nervous system (CNS), paranasal
sinus, kidney, bone marrow, etc. [1, 3–7]. Tissue diagno-
sis was made from the adrenal mass in four cases
through adrenalectomy, CT-guided biopsy and autopsy
specimen [1–3, 16], from cervical lymph nodes or nasal
mass in two cases. There was no pathologic diagnosis in
one case (the diagnosis was made per imaging study).
The ages of the patients ranged from 17 to 76. Among
these cases, the highly aggressive nature of the lymph-
oma and its rapid clinical progression were reported and
the long-term prognosis has not been observed
(Table. 1).
Because of the rarity of this disease, the standard
therapies have not been defined. The treatments have
included various combinations of surgery, chemother-
apy, and radiation. In the reported cases, four patients
received chemotherapy, one patient received surgery
and chemotherapy; one patient received high dose
intravenous dexamethasone, and one patient received
immunosuppression therapy. CHOP was the most
common used chemotherapy regimen in these re-
ported cases. The longest reported survival was
90 days in a patient who received surgery and chemo-
therapy. Our patient underwent surgery, postoperative
chemotherapy with 4 cycles of CHOP followed by
radiotherapy. Two more cycles of CHOP were admin-
istered afterwards. It should be noted that the surgery
was performed prior to the patient’s visit at our hos-
pital. If a biopsy sufficed, then surgery would not be
necessary, given that these tumors are generally sensi-
tive to chemotherapy and radiation therapy. Because
of the residual tumor at the left side of the
Fig. 3 The expression of EBER. Chromogenic in situ hybridization (CISH) was positive for the EBER gene. (magnification × 400)
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retroperitoneum, postoperative radiation therapy was
recommended. In terms of chemotherapy regimen,
SMILE (dexamethasone, methotrexate, ifosfamide, L-
asparaginase and etoposide) is a standard chemother-
apy regimen for NK/T lymphoma patients in the
western countries. However, there was a shortage of
L-asparaginase in our province in the end of 2013,
when this patient was first treated. Therefore, this pa-
tient was treated with CHOP according to the previ-
ous case reports [2, 5, 7]. As a side note, SMILE has
been used for NK/T lymphoma patients in our prov-
ince since mid-2014.
Our patient remains disease-free with a follow up of
over two years. We list three possible reasons for the
longer disease-free survival for our patient: (1) the NK/T
cell lymphoma only involved one adrenal gland; (2) the
NK/T cell lymphoma did not involve other organs, ex-
cept for the adjacent kidney; and (3) the utilization of
trimodality therapy.
Conclusion
In conclusion, primary adrenal NK/T cell lymphoma is
an exceedingly uncommon neoplasm and the outcomes
for it are generally poor. We present the first case of a
primary adrenal NK/T cell lymphoma in China with over
2-year disease-free survival treated with trimodality ther-
apy. NK/T cell lymphoma should be considered in the
differential diagnosis of a rapidly enlarging adrenal mass.
As reports of such cases increase and our understanding
of the disease improves, we anticipate more effective
treatment for these patients.
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